ReviewAdvances in therapy2020

Unlocking the Value of Anti-TNF Biosimilars: Reducing Disease Burden and Improving Outcomes in Chronic Immune-Mediated Inflammatory Diseases: A Narrative Review.

Mourad F Rezk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.